Champions Oncology (CSBR) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -317.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 501.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -173.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -684.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -522.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -6,872.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 1,748.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -8.87 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -981,044.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1,748.00 |
| Apr 30, 2026 | 1,586.00 |
| Jan 31, 2026 | 1,753.00 |
| Oct 31, 2025 | 171.00 |
| Jul 31, 2025 | -103.00 |
| Apr 30, 2025 | -1,321.00 |
| Jan 31, 2025 | 2,047.00 |
| Oct 31, 2024 | 303.00 |
| Jul 31, 2024 | 1,089.00 |
| Apr 30, 2024 | 471.00 |
| Jan 31, 2024 | -2,997.00 |
| Oct 31, 2023 | -1,796.00 |
| Jul 31, 2023 | -2,113.00 |
| Apr 30, 2023 | 426.00 |
| Jan 31, 2023 | -2,361.00 |
| Oct 31, 2022 | -418.00 |
| Jul 31, 2022 | 709.00 |
| Apr 30, 2022 | -74.00 |
| Jan 31, 2022 | 1,179.00 |
| Oct 31, 2021 | -155.00 |